Affiliation:
1. Department of Medicine, Hematology/Oncology Section, Stephenson Cancer Center, Center for Cancer Prevention and Drug Development, University of Oklahoma Health Sciences Center, VA Medical Center, Oklahoma City, Oklahoma.
Abstract
AbstractIn this issue of Cancer Prevention Research, Cecil and colleagues show that nonsteroidal anti-inflammatory drugs (NSAID), celecoxib and naproxen, decrease the expression of programmed death-ligand 1 (PD-L1) and increase the influx of Type I tumor-infiltrating lymphocytes in colonic tumors. Importantly, both decrease of PD-L1 expression and increase of CD8+ T cells were associated with the inhibition of COX-2/PGE2 pathway in vitro and syngeneic colonic tumor xenograft models. This study clearly suggests that NSAIDs regulate the intratumoral immunity multiple ways, including suppression of expression of immune checkpoint blockade. Thus, NSAIDs should be considered as chemopreventive for patients with PD-L1–positive colonic polyp.See related article, p. 225
Publisher
American Association for Cancer Research (AACR)
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献